Certara Shares Outstanding 2019-2021 | CERT

Certara shares outstanding history from 2019 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Certara shares outstanding for the quarter ending June 30, 2021 were 0.147B, a 11.39% increase year-over-year.
  • Certara 2020 shares outstanding were 0.133B, a 0.63% increase from 2019.
  • Certara 2019 shares outstanding were 0.132B, a 0% decline from 2018.
  • Certara 2018 shares outstanding were 0.132B, a INF% increase from .
Certara Annual Shares Outstanding
(Millions of Shares)
2020 133
2019 132
2018 132
Certara Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 147
2021-03-31 152
2020-12-31
2020-09-30
2020-06-30 132
2020-03-31 132
2019-12-31
2019-09-30
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.665B $0.244B
Certara Inc. provides medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Certara Inc. is based in NJ, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.838B 8.91
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.341B 20.90
Biohaven Pharmaceutical Holding (BHVN) United States $8.723B 0.00
Emergent Biosolutions (EBS) United States $2.813B 6.79
Arcus Biosciences (RCUS) United States $2.568B 0.00
Myovant Sciences (MYOV) United Kingdom $2.170B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.949B 0.00
Zymeworks (ZYME) Canada $1.323B 0.00
Ambrx Biopharma (AMAM) United States $0.509B 0.00
SQZ Biotechnologies (SQZ) United States $0.428B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29